Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00245258
Status:
COMPLETED
Last Update Posted:
2021-02-01
First Post:
2005-10-25
Brief Title:
Study to Evaluate Viagras Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
A Multicenter Double-Blind Placebo Controlled Fixed Dose Study With An Open-Label Flexible Dose Phase To Assess The Efficacy Of Sildenafil Citrate In Providing A Better Sexual Experience Including Quality Of Erections And Satisfaction In Men With Erectile Dysfunction
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study objective is to
1 To evaluate the effect of sildenafil citrate versus placebo on the IIEF_EF Domain at the end of the double-blind phase
2 To assess the relationship between treatment with sildenafil citrate or placebo and responses to the Quality of Erection Questionnaire QEQ and Sexual Experience Questionnaire SEX_Q
1 To evaluate the effect of sildenafil citrate versus placebo on the IIEF_EF Domain at the end of the double-blind phase
2 To assess the relationship between treatment with sildenafil citrate or placebo and responses to the Quality of Erection Questionnaire QEQ and Sexual Experience Questionnaire SEX_Q
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None